Phase III Study of Toripalimab（JS001） Combined With Lenvatinib for Advanced HCC
Clinical trial NCT04523493 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04523493
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-29
- Primary completion
- 2026-12-31
- Enrollment
- 530
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.